Megan Cramer

Megan is a cellular and molecular biologist with experience in muscle biology and developing therapies for neuromuscular disorders. She earned her PhD in Molecular, Cellular, and Developmental Biology from The Ohio State University where she worked at Nationwide Children’s Hospital to evaluate gene therapy approaches to muscular dystrophy and AAV immunogenicity in skeletal muscle. Prior to joining Dyno, she was a postdoctoral fellow in Pfizer’s Rare Disease Research Unit where she contributed to early drug discovery efforts for muscle disease indications. Megan enjoys the great outdoors, painting, and making others laugh at her bad jokes.